The COMBAT HBV Feasibility Trial (COMBAT-HBV)
Simplifying Hepatitis B Care in Pregnancy by Combining Birth-dose Vaccine and Tenofovir: The COMBAT HBV Feasibility Trial
Sponsor: Abbott
This PHASE4 trial investigates Hepatitis B and Vertical Transmission of Infectious Disease and is currently completed. Abbott leads this study, which shows 9 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE4
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Aug 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
May 2023 — Nov 2023 [monthly]
Not Yet Recruiting PHASE4
-
Mar 2023 — May 2023 [monthly]
Not Yet Recruiting PHASE4
-
Feb 2023 — Mar 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott
- Albert Einstein College of Medicine
- Doris Duke Charitable Foundation
- University of North Carolina, Chapel Hill
- Université Protestant au Congo
For direct contact, visit the study record on ClinicalTrials.gov .